Direct oral anticoagulants for the prevention of thromboembolic complications of atrial fibrillation: The more you pay, the less you spend?

被引：1
|
作者：
Brunetti, Natale Daniele [1 ]
De Gennaro, Luisa [2 ]
Caldarola, Pasquale [2 ]
Gaglione, Antonio [1 ]
Di Biase, Matteo [1 ]
机构：
[1] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy
[2] Osped San Paolo, Cardiol Dept, Bari, Italy
来源：
INTERNATIONAL JOURNAL OF CARDIOLOGY | 2017年 / 241卷
关键词：
Direct oral anticoagulants; Cost effectiveness analysis; Budget impact analysis; Break even point; COST-EFFECTIVENESS; WARFARIN; MANAGEMENT;
D O I：
10.1016/j.ijcard.2017.03.059
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：238 / 240
页数：3
相关论文
共 50 条
  • [21] Atrial Fibrillation: How effective and safe are the direct oral Anticoagulants for Prevention of Strokes?
    Hohnloser, Stefan H.
    Vamos, Mate
    Diener, Hans-Christoph
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (10) : 750 - U60
  • [22] ARTERIAL HYPERTENSION AS A PREDICTOR OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH DIRECT ORAL ANTICOAGULANTS
    Sinigoj, Petra
    Kabaklic, Amela
    Hitij, Jana Brguljan
    Mavri, Alenka
    JOURNAL OF HYPERTENSION, 2023, 41 : E90 - E90
  • [23] Rivaroxaban in the prevention of thromboembolic complications in patients with atrial fibrillation
    Gilyarov, M. Yu.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2012, 8 (03) : 453 - 456
  • [24] Current views on the prevention of thromboembolic complications in atrial fibrillation
    Bociek, Arkadiusz
    Manka, Ewa
    Bociek, Martyna
    Gmyrek, Joanna
    Sieron, Aleksander Romuald
    ACTA ANGIOLOGICA, 2018, 24 (02): : 44 - 50
  • [25] New score for predicting thromboembolic events in patients with atrial fibrillation using direct oral anticoagulants
    Ma, Fuxin
    Chen, Jiana
    Chang, Sijie
    Huang, Nianxu
    Zhang, Wang
    Dai, Hengfen
    Zheng, Qiaowei
    Li, Ruijuan
    Lin, Xiangsheng
    Liu, Yuxin
    Du, Xiaoming
    Su, Jun
    Huang, Xiaohong
    Chen, Xia
    Hu, Wei
    Liu, Xiumei
    Zhang, Yanxia
    Gu, Ping
    Zhang, Jinhua
    BLOOD COAGULATION & FIBRINOLYSIS, 2023, 34 (08) : 530 - 537
  • [26] THROMBOEMBOLIC COMPLICATIONS OF ATRIAL-FIBRILLATION AND THEIR PREVENTION - A REVIEW
    PETERSEN, P
    AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (06): : C24 - C28
  • [27] Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants
    Testa, Sophie
    Legnani, Cristina
    Antonucci, Emilia
    Paoletti, Oriana
    Dellanoce, Claudia
    Cosmi, Benilde
    Pengo, Vittorio
    Poli, Daniela
    Morandini, Rossella
    Testa, Roberto
    Tripodi, Armando
    Palareti, Gualtiero
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2019, 17 (07) : 1064 - 1072
  • [28] Cost-Effectiveness of Apixaban versus Other Direct Oral Anticoagulants and Warfarin in the Prevention of Thromboembolic Complications Among Finnish Patients with Non-Valvular Atrial Fibrillation
    Hallinen, Taru
    Soini, Erkki
    Asseburg, Christian
    Linna, Miika
    Eloranta, Pia
    Sintonen, Sari
    Kosunen, Mikko
    CLINICOECONOMICS AND OUTCOMES RESEARCH, 2021, 13 : 745 - 755
  • [29] Novel oral anticoagulants for stroke prevention in atrial fibrillation
    Taylor, Jennifer
    EUROPEAN HEART JOURNAL, 2012, 33 (12) : 1419 - 1420
  • [30] New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation
    Hilleman, Daniel E.
    AMERICAN JOURNAL OF PHARMACY BENEFITS, 2012, 4 (06) : 269 - 283
12345